{
  "id": "astrazeneca-signs-18-5b-deal-for-next-gen-slimming-drugs",
  "title": "AstraZeneca signs $18.5b deal for next-gen slimming drugs",
  "summary": "Big pharma AstraZeneca partners with Hong Kong’s CSPC to develop next-gen weight management drugs worldwide. Managing your weight is possible without complicated schedules, multiple pills or daily injections. That’s the vision British-Swedish pharma giant AstraZeneca is chasing with its latest move: a massive $18.5 billion licensing deal with Hong Kong-based CSPC Pharmaceutical Group to develop […] The post AstraZeneca signs $18.5b deal for next-gen slimming drugs appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/astrazeneca-signs-18-5b-deal-for-next-gen-slimming-drugs/",
  "source": "Longevity.Technology",
  "author": "Kyle Umipig",
  "category": "news",
  "publishedAt": "2026-02-03T18:23:58.000Z",
  "fetchedAt": "2026-02-04T10:49:05.813Z",
  "relevanceScore": 0.4,
  "matchedKeywords": [
    "longevity",
    "aging"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.866Z"
}